New Vaccines Data Have Been Reported by Investigators at Columbia University Medical Center (A Randomised Phase Ii Trial of a Trivalent Ganglioside Vaccine Targeting Gm2, Gd2 and Gd3 Combined With Immunological Adjuvant Opt-821 Versus Opt-821 ...)

  • Gary Schwartz

Press/Media

Period5 Dec 2022

Media coverage

1

Media coverage

  • TitleNew Vaccines Data Have Been Reported by Investigators at Columbia University Medical Center (A Randomised Phase Ii Trial of a Trivalent Ganglioside Vaccine Targeting Gm2, Gd2 and Gd3 Combined With Immunological Adjuvant Opt-821 Versus Opt-821 ...)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date5/12/22
    URLct.moreover.com/?a=49431512995&p=1gw&v=1&x=yTowqUfyEg4ZDa-seBHsVA
    PersonsGary Schwartz